angiotensin ii has been researched along with ursodeoxycholic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouscarel, B; Dubner, H; Fromm, H; Gettys, TW | 1 |
| Bouscarel, B; Ceryak, S; Fromm, H; Gettys, TW; Le, M; Matsuzaki, Y; Shoda, J | 1 |
| Bouscarel, B; Fromm, H; Gettys, TW; Le, M; Matsuzaki, Y | 1 |
| He, X; Li, Z; Liu, W; Liu, X; Liu, Y; Wang, B; Wang, T; Zeng, H | 1 |
| Al-Salami, H; Elahy, M; Lam, V; Mamo, JC; Mooranian, A; Negrulj, R; Takechi, R | 1 |
| Chan, SMH; Herbert, TP; Ku, JM; Lau, YS; Miller, AA; Potocnik, S; Woodman, OL; Ye, JM | 1 |
6 other study(ies) available for angiotensin ii and ursodeoxycholic acid
| Article | Year |
|---|---|
Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC.
Topics: Angiotensin II; Animals; Bile Acids and Salts; Calcium; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Liver; Male; Mesocricetus; Protein Kinase C; Receptors, Glucagon; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid | 1995 |
Effect of cholestasis on regulation of cAMP synthesis by glucagon and bile acids in isolated hepatocytes.
Topics: Angiotensin II; Animals; Bile; Bile Acids and Salts; Cells, Cultured; Cholestasis; Colforsin; Common Bile Duct; Cricetinae; Cyclic AMP; Glucagon; Isoenzymes; Kinetics; Liver; Male; Mesocricetus; Protein Kinase C; Protein Kinase C-alpha; Receptors, Glucagon; Reference Values; Taurocholic Acid; Ursodeoxycholic Acid | 1997 |
Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL.
Topics: Angiotensin II; Animals; Cholestasis; Colforsin; Common Bile Duct; Cricetinae; Cyclic AMP; Glucagon; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; GTP-Binding Proteins; Keratins; Ligation; Liver; Male; Mesocricetus; Receptors, Glucagon; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 1998 |
Ursodeoxycholic Acid Attenuates Acute Aortic Dissection Formation in Angiotensin II-Infused Apolipoprotein E-Deficient Mice Associated with Reduced ROS and Increased Nrf2 Levels.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Apoptosis; bcl-2-Associated X Protein; Cells, Cultured; Cholagogues and Choleretics; Disease Models, Animal; Down-Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Up-Regulation; Ursodeoxycholic Acid | 2016 |
Long-Term Supplementation of Microencapsulated ursodeoxycholic Acid Prevents Hypertension in a Mouse Model of Insulin Resistance.
Topics: Angiotensin II; Animals; Capsules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Hypertension; Insulin Resistance; Male; Mice; Time Factors; Ursodeoxycholic Acid | 2017 |
Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response.
Topics: Angiotensin II; Animals; Cell Line, Tumor; Cytokines; Diabetes Mellitus, Type 2; eIF-2 Kinase; Endoplasmic Reticulum Stress; Endoribonucleases; Gene Expression; Gene Knockdown Techniques; Glucose; Inflammation; Inositol 1,4,5-Trisphosphate Receptors; Insulin-Secreting Cells; Insulinoma; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Renin-Angiotensin System; RNA, Small Interfering; Taurine; Ursodeoxycholic Acid | 2017 |